{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:32:23Z","timestamp":1789453943823,"version":"build-2803163510"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Federal Office for Economic Affairs","award":["KMU 161B0760B"],"award-info":[{"award-number":["KMU 161B0760B"]}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SFB 1557 Z2"],"award-info":[{"award-number":["SFB 1557 Z2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cell therapeutic applications based on induced pluripotent stem cells (iPSCs) appear highly promising and challenging at the same time. Good manufacturing practice (GMP) regulations impose necessary yet demanding requirements for quality and consistency when manufacturing iPSCs and their differentiated progeny. Given the scarcity of accessible GMP iPSC lines, we have established a corresponding production workflow to generate the first set of compliant cell banks. Hence, these lines met a comprehensive set of release specifications and, for instance, displayed a low overall mutation load reflecting their neonatal origin, cord blood. Based on these iPSC lines, we have furthermore developed a set of GMP-compatible workflows enabling improved gene targeting at strongly enhanced efficiencies and directed differentiation into critical cell types: A new protocol for the generation of retinal pigment epithelium (RPE) features a high degree of simplicity and efficiency. Mesenchymal stromal cells (MSCs) derived from iPSCs displayed outstanding expansion capacity. A fully optimized cardiomyocyte differentiation protocol was characterized by a particularly high batch-to-batch consistency at purities above 95%. Finally, we introduce a universal immune cell induction platform that converts iPSCs into multipotent precursor cells. These hematopoietic precursors could selectively be stimulated to become macrophages, T cells, or natural killer (NK) cells. A switch in culture conditions upon NK-cell differentiation induced a several thousand-fold expansion, which opens up perspectives for upscaling this key cell type in a feeder cell-independent approach. Taken together, these cell lines and improved manipulation platforms will have broad utility in cell therapy as well as in basic research.<\/jats:p>","DOI":"10.1093\/stcltm\/szae047","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T09:57:50Z","timestamp":1718877470000},"page":"898-911","source":"Crossref","is-referenced-by-count":22,"title":["GMP-compliant iPS cell lines show widespread plasticity in a new set of differentiation workflows for cell replacement and cancer immunotherapy"],"prefix":"10.1093","volume":"13","author":[{"given":"Daniel","family":"Terheyden-Keighley","sequence":"first","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"H\u00fchne","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Hiller","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraia","family":"Martins","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gamerschlag","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Sabour","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Meffert","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kislat","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Slotta","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Hafezi","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Lichte","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Sudheer","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Tessmer","sequence":"additional","affiliation":[{"name":"Center for Regenerative Therapies Dresden (CRTD) and Center for Molecular and Cellular Bioengineering, Dresden University of Technology , 01307 Dresden , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherina","family":"Psathaki","sequence":"additional","affiliation":[{"name":"Center for Cellular Nanoanalytics (CellNanOs), University of Osnabr\u00fcck , 49076 Osnabr\u00fcck , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Ader","sequence":"additional","affiliation":[{"name":"Center for Regenerative Therapies Dresden (CRTD) and Center for Molecular and Cellular Bioengineering, Dresden University of Technology , 01307 Dresden , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesine","family":"Kogler","sequence":"additional","affiliation":[{"name":"Institute of Transplantation Diagnostics and Cell Therapeutics and Jose Carreras Stem Cell Bank, University Hospital of D\u00fcsseldorf , 40225 D\u00fcsseldorf , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9404-7293","authenticated-orcid":false,"given":"Boris","family":"Greber","sequence":"additional","affiliation":[{"name":"Catalent D\u00fcsseldorf GmbH , 40764 Langenfeld , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"issue":"9","key":"2024091019005778100_CIT0001","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3390\/biomedicines10092281","article-title":"Recent advances in extracellular vesicle-based therapies using induced pluripotent stem cell-derived mesenchymal stromal cells","volume":"10","author":"Bertolino","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"2024091019005778100_CIT0002","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.3390\/cancers14092266","article-title":"Engineering induced pluripotent stem cells for cancer immunotherapy","volume":"14","author":"Zhou","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"2024091019005778100_CIT0003","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.stemcr.2020.06.014","article-title":"A manually curated database on clinical studies involving cell products derived from human pluripotent stem cells","volume":"15","author":"Kobold","year":"2020","journal-title":"Stem Cell Rep"},{"issue":"3","key":"2024091019005778100_CIT0004","doi-asserted-by":"crossref","first-page":"101582","DOI":"10.1016\/j.xpro.2022.101582","article-title":"Triphasic developmentally guided protocol to generate retinal pigment epithelium from induced pluripotent stem cells","volume":"3","author":"Sharma","year":"2022","journal-title":"STAR Protoc"},{"issue":"4","key":"2024091019005778100_CIT0005","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.stemcr.2020.02.006","article-title":"Generation of retinal pigment epithelial cells derived from human embryonic stem cells lacking human leukocyte antigen class I and II","volume":"14","author":"Petrus-Reurer","year":"2020","journal-title":"Stem Cell Rep"},{"issue":"6","key":"2024091019005778100_CIT0006","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.stem.2010.11.011","article-title":"A mesoderm-derived precursor for mesenchymal stem and endothelial cells","volume":"7","author":"Vodyanik","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"8","key":"2024091019005778100_CIT0007","doi-asserted-by":"crossref","first-page":"e13248","DOI":"10.1111\/cpr.13248","article-title":"Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy","volume":"55","author":"Morita","year":"2022","journal-title":"Cell Prolif"},{"key":"2024091019005778100_CIT0008","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4939-9728-2_12","article-title":"An improved method to produce clinical-scale natural killer cells from human pluripotent stem cells","volume":"2048","author":"Zhu","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"3","key":"2024091019005778100_CIT0009","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2024091019005778100_CIT0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent stem cell-based cell therapy-promise and challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2024091019005778100_CIT0011","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/vox.12978","article-title":"GMP-grade CD34(+) selection from HLA-homozygous licensed cord blood units and short-term expansion under European ATMP regulations","volume":"116","author":"Liedtke","year":"2021","journal-title":"Vox Sang"},{"issue":"3","key":"2024091019005778100_CIT0012","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/stem.1293","article-title":"An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells","volume":"31","author":"Okita","year":"2013","journal-title":"Stem Cells"},{"issue":"3","key":"2024091019005778100_CIT0013","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.stem.2015.11.019","article-title":"Stepwise clearance of repressive roadblocks drives cardiac induction in human ESCs","volume":"18","author":"Rao","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"24","key":"2024091019005778100_CIT0014","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1038\/emboj.2011.407","article-title":"FGF signalling inhibits neural induction in human embryonic stem cells","volume":"30","author":"Greber","year":"2011","journal-title":"EMBO J"},{"issue":"6","key":"2024091019005778100_CIT0015","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nbt1310","article-title":"A ROCK inhibitor permits survival of dissociated human embryonic stem cells","volume":"25","author":"Watanabe","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2024091019005778100_CIT0016","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2024091019005778100_CIT0017","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.celrep.2018.06.091","article-title":"Insights into the mutational burden of human induced pluripotent stem cells from an integrative multi-omics approach","volume":"24","author":"D\u2019Antonio","year":"2018","journal-title":"Cell Rep"},{"issue":"1","key":"2024091019005778100_CIT0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.stemcr.2019.12.004","article-title":"Recurrent genetic abnormalities in human pluripotent stem cells: definition and routine detection in culture supernatant by targeted droplet digital PCR","volume":"14","author":"Assou","year":"2020","journal-title":"Stem Cell Rep"},{"issue":"11","key":"2024091019005778100_CIT0019","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC cancer gene census: describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"35","key":"2024091019005778100_CIT0020","doi-asserted-by":"crossref","first-page":"10950","DOI":"10.1073\/pnas.1422818112","article-title":"Small-molecule-directed, efficient generation of retinal pigment epithelium from human pluripotent stem cells","volume":"112","author":"Maruotti","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"2024091019005778100_CIT0021","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1242\/dev.127.21.4599","article-title":"Extraocular mesenchyme patterns the optic vesicle during early eye development in the embryonic chick","volume":"127","author":"Fuhrmann","year":"2000","journal-title":"Development"},{"issue":"3","key":"2024091019005778100_CIT0022","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stemcr.2020.02.004","article-title":"MERTK-dependent ensheathment of photoreceptor outer segments by human pluripotent stem cell-derived retinal pigment epithelium","volume":"14","author":"Almedawar","year":"2020","journal-title":"Stem Cell Rep"},{"key":"2024091019005778100_CIT0023","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.scr.2018.08.015","article-title":"A complete workflow for the differentiation and the dissociation of hiPSC-derived cardiospheres","volume":"32","author":"Fischer","year":"2018","journal-title":"Stem Cell Res"},{"key":"2024091019005778100_CIT0024","doi-asserted-by":"crossref","first-page":"13602","DOI":"10.1038\/ncomms13602","article-title":"Bulk cell density and Wnt\/TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells","volume":"7","author":"Kempf","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"2024091019005778100_CIT0025","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/s41598-018-20358-5","article-title":"\u2018Cold shock\u2019 increases the frequency of homology directed repair gene editing in induced pluripotent stem cells","volume":"8","author":"Guo","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"2024091019005778100_CIT0026","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ncb3205","article-title":"Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells","volume":"17","author":"Patsch","year":"2015","journal-title":"Nat Cell Biol"},{"issue":"9","key":"2024091019005778100_CIT0027","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1007\/s00018-021-03777-y","article-title":"The hemogenic endothelium: a critical source for the generation of PSC-derived hematopoietic stem and progenitor cells","volume":"78","author":"Lange","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"2024091019005778100_CIT0028","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3324\/haematol.2019.228064","article-title":"A 3D iPSC-differentiation model identifies interleukin-3 as a regulator of early human hematopoietic specification","volume":"106","author":"Ackermann","year":"2021","journal-title":"Haematologica"},{"issue":"3","key":"2024091019005778100_CIT0029","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1182\/blood.V98.3.705","article-title":"Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2\/L3\/S2","volume":"98","author":"Miller","year":"2001","journal-title":"Blood"},{"issue":"5","key":"2024091019005778100_CIT0030","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nprot.2008.42","article-title":"A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies","volume":"3","author":"Ng","year":"2008","journal-title":"Nat Protoc"},{"issue":"4","key":"2024091019005778100_CIT0031","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.stemcr.2015.08.015","article-title":"cGMP-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications","volume":"5","author":"Baghbaderani","year":"2015","journal-title":"Stem Cell Rep"},{"issue":"2 Suppl","key":"2024091019005778100_CIT0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/rme.14.93","article-title":"Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)","volume":"10","author":"Andrews","year":"2015","journal-title":"Regen Med"},{"issue":"5","key":"2024091019005778100_CIT0033","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.stem.2019.04.001","article-title":"Highly efficient and marker-free genome editing of human pluripotent stem cells by CRISPR-Cas9 RNP and AAV6 Donor-mediated homologous recombination","volume":"24","author":"Martin","year":"2019","journal-title":"Cell Stem Cell"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/13\/9\/898\/59076596\/szae047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/13\/9\/898\/59076596\/szae047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T15:07:23Z","timestamp":1725980843000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/13\/9\/898\/7718677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,7,23]]},"published-print":{"date-parts":[[2024,9,10]]}},"URL":"https:\/\/doi.org\/10.1093\/stcltm\/szae047","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,7,23]]}}}